St. Louis VC firm RiverVest closes on $74m second fund

The Missouri biotech-focussed firm has beaten its previous fund by $30m.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this